PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.10
ESG score 90-95% of AFMD's 61.89. Bill Ackman would demand clear ESG improvement catalysts.
51.50
Environmental score 80-90% of AFMD's 58.09. Walter Schloss would scrutinize carbon exposure and transition planning.
59.70
Social score 80-90% of AFMD's 66.39. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
60.10
Similar governance score to AFMD's 61.19. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.